InsidersTradesSigma
Track the 杏林製薬株式会社 stock price and the full management transaction log of the company, a publicly traded company based in Japan. Shares are listed on JP JP, under the authority of EDINET (Japan FSA). Operating in the Health Care sector, 杏林製薬株式会社 has logged 11 insider filings. Market capitalisation: €65.6bn. The latest transaction was reported on 5 August 2026 (Holding update). Among the most active insiders: Kopernik Global Investers, LLC. Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
11 of 11 declarations
杏林製薬株式会社 is a Japanese company specializing in the health and pharmaceutical sector. It is listed on the XTKS market.